ESTRO 38 - Programme Book & Exhibition Guide

JOINT SYMPOSIUM ESTRO-JASTRO: Clinical trials for particle therapy: which ones to run and how? 10:30 - 11:45 | Auditorium The aim of this interdisciplinary session is to address the important topic of clinical trials for proton therapy. First, the importance of international research networking to design and perform trials cannot be overexpressed. High-quality data collection is key in producing high- quality data that particle therapy is critically lacking. Second, quality assurance (QA) performed within the framework of a clinical trial, as in conventional radiotherapy, assures that particle radiation is delivered accurately as per protocol and consistently between accruing centers. Fundamental questions such as to why QA is needed for clinical trials with particles, what is currently being done for particle trials by clinical trial QA groups and most importantly what is missing in the QA process relating to particles. From a radiobiologiocal point of view the limitations of current RBE models and their implication for clinical particle trials are important and should be debated. Finally, an overview of clinical trials in carbon ion therapy will be given in the final talk. 10:30 > International collaborations in proton therapy: networks, trials and data collection Speaker: C. Grau (Denmark) 10:48 > Trial quality assurance and audits for proton therapy Speaker: C. Clark (United Kingdom) 11:06 > Limitations of current RBE models and their implication for clinical trial design Speaker: N. Matsufuji (Japan) 11:18 > Clinical trials on carbon ion radiotherapy for locally advanced pancreatic cancer Speaker: T. Ohno (Japan) Chair: D.C. Weber (Switzerland) Chair: Y. Nagata (Japan)

SUNDAY 28 APRIL 2019

SP-0260

SP-0261

SP-0262

SP-0263

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

116

Made with FlippingBook Learn more on our blog